ClinicalTrials.Veeva

Menu

Seroprevalence of Pertussis Among Children and Adolescents in Croatia

U

University Hospital for Infectious Diseases, Croatia

Status

Unknown

Conditions

Immunogenicity, Vaccine

Treatments

Diagnostic Test: ELISA IgG Testkit

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT04725669
UHID-06

Details and patient eligibility

About

Pertussis is a vaccine preventable disease caused by Bordetella pertussis. Older children and adolescents with pertussis continue to be a significant source of infection for incompletely vaccinated infants who are in harm for developing severe disease. The primary objective of our study is to estimate the duration of protection elicited by the current vaccination schedule against pertussis in Croatia.

Enrollment

1,500 estimated patients

Sex

All

Ages

6 to 18 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • children and adolescents from 6 to 18 years of age treated through Emergency room and/or Day hospital of Pediatric Infectious Diseases Department at UHID;
  • appropriate vaccination with pertussis component containing vaccine by date and at the appropriate time, according to Croatian NIP proven by insight in the Vaccination Record Card
  • written informed consent obtained from the subject's parent or caregiver, as well as from participants ≥ 16 years old.

Exclusion criteria

  • children under 6 years
  • children and adolescents with acute respiratory symptoms
  • children and adolescents with pertussis-like illness within 12 months
  • children and adolescents with unknown, uncompleted or irregular vaccination record
  • inpatients
  • children and adolescents with immunodeficiencies

Trial design

Primary purpose

Prevention

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

1,500 participants in 1 patient group

Seroprevalence of pertussis among children and adolescents in Croatia
Other group
Description:
For all patients participating in the study one serum sample will be collected for serological analysis.
Treatment:
Diagnostic Test: ELISA IgG Testkit

Trial contacts and locations

1

Loading...

Central trial contact

Vedran Stevanović; Goran Tešović

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems